Center for Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Cell. 2021 Aug 19;184(17):4447-4463.e20. doi: 10.1016/j.cell.2021.07.026. Epub 2021 Aug 6.
TANK binding kinase 1 (TBK1) regulates IFN-I, NF-κB, and TNF-induced RIPK1-dependent cell death (RCD). In mice, biallelic loss of TBK1 is embryonically lethal. We discovered four humans, ages 32, 26, 7, and 8 from three unrelated consanguineous families with homozygous loss-of-function mutations in TBK1. All four patients suffer from chronic and systemic autoinflammation, but not severe viral infections. We demonstrate that TBK1 loss results in hypomorphic but sufficient IFN-I induction via RIG-I/MDA5, while the system retains near intact IL-6 induction through NF-κB. Autoinflammation is driven by TNF-induced RCD as patient-derived fibroblasts experienced higher rates of necroptosis in vitro, and CC3 was elevated in peripheral blood ex vivo. Treatment with anti-TNF dampened the baseline circulating inflammatory profile and ameliorated the clinical condition in vivo. These findings highlight the plasticity of the IFN-I response and underscore a cardinal role for TBK1 in the regulation of RCD.
TANK 结合激酶 1(TBK1)调节 IFN-I、NF-κB 和 TNF 诱导的 RIPK1 依赖性细胞死亡(RCD)。在小鼠中,TBK1 的双等位基因缺失是胚胎致死的。我们发现了来自三个无关近亲家庭的四名患者,年龄分别为 32 岁、26 岁、7 岁和 8 岁,他们均存在 TBK1 纯合失活功能突变。所有四名患者均患有慢性和全身性自身炎症,但没有严重的病毒感染。我们证明 TBK1 的缺失导致 IFN-I 的低功能诱导,通过 RIG-I/MDA5,而该系统通过 NF-κB 保留近乎完整的 IL-6 诱导。自身炎症是由 TNF 诱导的 RCD 驱动的,因为患者来源的成纤维细胞在体外经历更高的坏死性凋亡率,并且在体外循环中 CC3 升高。抗 TNF 治疗减轻了基线循环炎症谱,并改善了体内的临床状况。这些发现强调了 IFN-I 反应的可塑性,并突出了 TBK1 在调节 RCD 中的主要作用。